Barclays‘ (LSE:BARC) shares are rapidly becoming one of the more divisive assets on the FTSE 100. On Friday (23 October), major broker Citi slashed its price target to 460p while maintaining a Neutral rating.

Meanwhile, UBS has a 588p target and Goldman Sachs sits at 700p. I understand the caution, but 460p feels too pessimistic.

The shares closed at 409.45p on 22 October after falling 2.03%. That leaves a wide gap to the more optimistic broker views. So is the weakness a warning, or an opportunity for patient investors?

Why investors are nervous

The bear case isn’t unreasonable. Barclays’ third-quarter pre-tax profit rose 12% to £2.3bn, but missed the roughly £2.4bn analysts expected.

The main problem was fixed income, currencies and commodities (FICCs). Income from that division fell 19%, a big drop that reveals just how rapidly earnings can change from one quarter to the next.

It also plans to cut around 5,000 jobs, roughly 5% of its workforce, as it uses AI and technology to improve efficiency. That could help margins, but restructuring seldom goes smoothly.

Compounding the pain, the Bank of England’s examining the bank’s handling of private-credit exposures. Barclays says it takes regulatory obligations seriously, but such scrutiny’s never something investors ignore.

Why 460p looks too harsh

Still, I think the pessimistic target may understate what Barclays is delivering. The bank reported a return on tangible equity (RoTE) of 11.7% in the third quarter, with a year-to-date figure of 13.8%.

Management remains confident of delivering above 12% for 2026.

The bank also reaffirmed full-year income guidance of about £31.5bn, roughly 8% growth, while standing firm on its 2028 ambition of RoTE above 14%.

That shows confidence – and it’s not just hopeful. A further £500m share buyback supports the case, bringing its total 2026 distributions to £2.8bn. That’s a huge 46% year on year increase.

If it delivers even close to these targets, 460p seems to price in a whole litany of failures, rather than a few problems.

What RoTE really means

RoTE measures the profit a bank generates on shareholders’ tangible equity. If a bank earns more than its cost of equity, it should, over time, be worth more than the value of its tangible net assets.

Barclays’ CET1 capital ratio was 14.2% in the third quarter, giving management room to keep returning cash while maintaining a strong capital position. Buybacks also reduce the share count, which can support earnings per share (EPS) even when revenue growth is uneven.

In my view, 460p assumes the bank will fail to convert any of these plans into durable returns.

What could go wrong

I’m not saying Barclays is flawless, but its guidance, capital returns and improving RoTE are encouraging. Overall, I think 460p is excessively cautious and the shares still deserve consideration.

That said, potential investors should keep an eye on several risks:

• A continued fall in investment banking income, especially if FICC weakness persists.
• Higher loan losses or a weaker UK credit cycle.
• An unfavourable outcome from the reported regulatory scrutiny of private-credit exposures.
• AI-related savings being offset by higher technology or restructuring costs.

Long story short: this isn’t a ‘Buy at any price’ call, simply a view that the bear case may already be too harsh. But if you’re on Citi’s side, we’ve identified one high-growth stock you might like more…

What growth stock do we like better than Barclays Plc right now?

One of our Share Advisor analysts has just released a brand new stock report that we think is a must-read for any investor looking to try and generate potential growth.

And the best bit is that you can see it for yourself, right now, absolutely free of charge!

No jargon. No hard sell. Just a clear look at a growth share idea we think is worth your time.

Mark Hartley does not hold any positions in the companies mentioned.